Over 10 years we help companies reach their financial and branding goals. Maxbizz is a values-driven consulting agency dedicated.

Gallery

Contact

+1-800-456-478-23

411 University St, Seattle

maxbizz@mail.com

With sales momentum, Bookshop.org looks to future in its fight with Amazon

With sales momentum, Bookshop.org looks to future in its fight with Amazon

If Gutenberg were alive today, he’d be a very busy angel investor. With book sales booming during the COVID-19 lockdowns last year, the humble written word has suddenly drawn the limelight from VCs and founders. We’ve seen a whole cavalcade of new products and fundings, including algorithmic recommendation engine BingeBooks, book club startups like Literati…

Technology giant Olympus hit by BlackMatter ransomware

Technology giant Olympus hit by BlackMatter ransomware

Olympus said in a brief statement Sunday that it is “currently investigating a potential cybersecurity incident” affecting its European, Middle East and Africa computer network. “Upon detection of suspicious activity, we immediately mobilized a specialized response team including forensics experts, and we are currently working with the highest priority to resolve this issue. As part…

the street news image

Andes Wealth Technologies Named Winner In The Risk Tolerance/Client Profiling Category In The WealthManagement.com 2021 Industry Awards

BOSTON, Sept 13, 2021 /PRNewswire/ — Andes Wealth Technologies, an innovative wealth technology company, announced today that it has won the WealthManagement.com 2021 Industry Award in the Risk Tolerance/Client Profiling category. Combining behavioral finance with Risk Tolerance Test, Andes platform takes the risk conversation to a whole new level. Combining behavioral finance with its intuitive Risk…

the street news image

Hummingbird Bioscience Announces US FDA Clearance Of IND For First-in-Human Phase 1 Trial Of HMBD-002 In Patients With Advanced Solid Tumors

HOUSTON and SINGAPORE, Sept. 13, 2021 /PRNewswire/ — Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that the U.S. Food and Drug Administration (FDA) has approved the initiation of a Phase 1 clinical trial of HMBD-002, Hummingbird’s anti-VISTA neutralizing antibody. HMBD-002 is being developed for the…

Indonesia-based Rey Assurance launches its holistic approach to insurance with $1M in funding

Indonesia-based Rey Assurance launches its holistic approach to insurance with $1M in funding

Rey Assurance co-founders Bobby Siagian and Evan Tanotogono Health insurance is the kind of thing people usually only think about only when they need it. Otherwise, their policies are just paperwork in their files or cards in their wallet. Indonesian insurtech Rey Assurance is taking a new approach. Once someone becomes a member, they also…

To Win The War For Talent, Amazon Will Pay ‘Full College Tuition For Frontline Workers’

To Win The War For Talent, Amazon Will Pay ‘Full College Tuition For Frontline Workers’

Share to FacebookShare to TwitterShare to Linkedin (Photo by Alexandra Villa Loarca/Newsday RM via Getty Images) Newsday via Getty Images Amazon will pay full college tuition for frontline workers, according to a company blog post. The giant online retailer said, “More than 750,000 operations employees in the U.S. are eligible for fully funded college tuition,…

Tesla should say something

Tesla should say something

Last weekend, a reader wrote to this editor, politely asking why tech companies should speak up about the abortion law that Texas passed last week. “What does American Airlines have to do with abortion?” said the reader, suggesting that companies can’t possibly cater to both pro-abortion and anti-abortion advocates and that asking them to take…

Pfizer-BioNTech To Seek Approval For First Covid Vaccine For Young Children ‘In Next Few Weeks’

Pfizer-BioNTech To Seek Approval For First Covid Vaccine For Young Children ‘In Next Few Weeks’

Share to FacebookShare to TwitterShare to LinkedinTopline The companies behind the Pfizer vaccine are nearly ready to seek approval for the jab’s use among children as young as five years old and should make that request within the next few weeks, the founders of vaccine maker BioNTech said in an interview published Friday.  A student…